Large-scale testing (Phase 3)Study completedNCT04592419
What this trial is testing
Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)
Who this might be right for
Macular EdemaRetinal Vein Occlusion
Kodiak Sciences Inc 568